Full Press Release Details
AC Immune Initiates IND Enabling Studies For First in Class Antibody Targeting TDP 43 to Treat Neurodegeneration.
ACIU
AC Immune Initiates IND Enabling Studies For First in Class Antibody Targeting TDP 43 to Treat Neurodegeneration
Key Takeaway: AC Immune Initiates IND Enabling Studies For First in Class Antibody Targeting TDP 43 to Treat Neurodegeneration